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Abstract
Multidrug-resistant and New Delhi metallo-b-lactamase 1 (NDM-1) -producing Acinetobacter baumannii are increasingly reported. A col-
lection of ﬁve NDM-1-positive A. baumannii isolates recovered in four European countries were analysed. Genotyping was performed
by pulsed-ﬁeld gel electrophoresis, multiplex PCR sequence typing, Diversilab and multilocus sequence typing. Three distinct sequence
types were identiﬁed. All isolates harboured a chromosomally located blaNDM-1 gene within a Tn125-like transposon. One isolate co-
expressed another unrelated carbapenemase OXA-23. This report constitutes the ﬁrst epidemiological study of NDM-1-producing
A. baumannii from four countries.
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Abstract
A plasmid (pP2G1), which confers multidrug resistance in an environmental Aeromonas species, was completely sequenced using a shot-
gun approach. Plasmid pP2G1 encoded resistance to aminoglycosides and quinolones [aac(6¢)-Ib-cr], b-lactams (blaOXA-1), chlorampheni-
col (catB3), macrolides [mphA-mrx-mphR], quaternary ammonium compounds (qacED1), quinolones (qnrS2), rifampicin (arr-3) and
sulphonamides (sul1). These ﬁndings suggest that Aeromonas species may potentially act as reservoirs of antibiotic resistance genes.
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Abstract
Recently, the ﬁrst outbreak of clonally related VIM-2 metallo-b-lactamase (MBL)-producing Pseudomonas aeruginosa in a Dutch tertiary-
care centre was described. Subsequently, a nationwide surveillance study was performed in 2010–2011, which identiﬁed the presence of
VIM-2 MBL-producing P. aeruginosa in 11 different hospitals. Genotyping by multiple-locus variable-number tandem-repeat analysis
(MLVA) showed that the majority of the 82 MBL-producing isolates found belonged to a single MLVA type (n = 70, 85%), identiﬁed as
ST111 by multilocus sequence typing (MLST). As MBL-producing isolates cause serious infections that are difﬁcult to treat, the presence
of clonally related isolates in various hospitals throughout the Netherlands is of nationwide concern.
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